NCT03595202View on ClinicalTrials.gov

Clinical Study of TS-143 in Healthy Adult Male Subjects (Multiple-Dose Administration)

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 3, 2017

Primary Completion Date

July 7, 2017

Study Completion Date

July 7, 2017

Conditions
Healthy Participants
Interventions
DRUG

TS-143

Subjects should take 4 capsules once and 3 times per day in step 1. Subjects should take 2 capsules once and 3 times per day in step 2.

DRUG

Placebo

Subjects should take 4 capsules once and 3 times per day in step 1. Subjects should take 2 capsules once and 3 times per day in step 2.

Trial Locations (1)

Unknown

Taisho Pharmaceutical Co., Ltd selected site, Tokyo

All Listed Sponsors
lead

Taisho Pharmaceutical Co., Ltd.

INDUSTRY

NCT03595202 - Clinical Study of TS-143 in Healthy Adult Male Subjects (Multiple-Dose Administration) | Biotech Hunter | Biotech Hunter